Ant Finance's Aifu and Hebei Cancer Hospital Achieve Research Breakthrough in Cancer: Using AI to Predict Postoperative Risks of Gastric Cancer in Advance
Published on · Sep 9 · Wed Source · 雷峰网 (CN)

Ant Finance's Aifu and Hebei Cancer Hospital Achieve Research Breakthrough in Cancer: Using AI to Predict Postoperative Risks of Gastric Cancer in Advance

The Fourth Hospital of Hebei Medical University and the Ant Finance Aifu team developed an AI model named DeepComp, which can use CT scans before gastric cancer surgery to predict postoperative complications and survival risks. The related findings were published in Annals of Oncology.

Key Takeaways

  • Key Highlight:The Fourth Hospital of Hebei Medical University and the Ant Finance Aifu team developed an AI model named DeepComp, which can use CT scans before gastric cancer surgery to predict postoperative complications and survival risks. The related findings were published in Annals of Oncology.
  • Innovation & Tech:Highlights advancements in Ant, Finance, Aifu, demonstrating rapid progress in model capabilities.
  • Industry Impact:Reported via 雷峰网 (CN), offering actionable signals for developers and technology leaders.
KeywordsAntFinanceAifuHebeiCancerHospitalAchieveResearch

This is a typical study applying artificial intelligence to precision oncology. The research team used routine contrast-enhanced CT and clinical data to predict the probability of moderate-to-severe postoperative complications and long-term survival risks before gastric cancer surgery. The model is named DeepComp, and the related paper was accepted by the oncology journal Annals of Oncology.

The significance of this study lies in moving the AI prediction window forward. Previously, assessment of postoperative risks for gastric cancer mostly relied on postoperative pathology or perioperative observation. DeepComp can provide risk prediction before surgery begins, helping doctors formulate more refined preoperative communication and perioperative management plans.

It is worth noting that this is the third related study published by the same team in recent times. The previous two models targeted early postoperative recurrence and postoperative liver metastasis respectively, and the papers were published in Nature Communications. The three studies cover different time points along the treatment journey, forming a complete prediction system from preoperative to postoperative follow-up.

AI models of this kind can help promote more efficient allocation of medical resources. High-risk patients can benefit from preoperative intervention, while low-risk patients may avoid unnecessary treatment intensification, thereby guiding individualized decision-making and optimization of clinical pathways.

This achievement also reflects that the integration of AI with vertical medical scenarios is accelerating. Prediction models based on routine imaging and structured data have the potential for clinical implementation. If prospectively validated in the future, they are expected to become practical tools in gastrointestinal tumor risk management.

This page provides an editorial summary based on publicly available information. It is not a republished article. Use the source link below for the original report.

Industry Insights & Analysis

As artificial intelligence rapidly evolves, breakthroughs surrounding Ant, Finance, Aifu, Hebei are shifting toward scalable, robust real-world implementations.

Driven by both open-source ecosystems and proprietary model architectures, the integration between compute optimization, data engineering, and agentic workflows is accelerating. This development provides a strategic benchmark for upcoming AI tooling and developer workflows.